New! Sign up for our free email newsletter.
Science News
from research organizations

New laser provides cutting-edge treatment for diabetes, retinal diseases

Date:
September 24, 2013
Source:
University of Nebraska Medical Center (UNMC)
Summary:
A new laser in Nebraska - one of only two in the world -- can help prevent blindness in patients with diabetes and retinal eye diseases.
Share:
FULL STORY

A new laser is helping experts at the Truhlsen Eye Institute at the University of Nebraska Medical Center provide better treatment for eye diseases. This advanced laser can prevent blindness for some patients with serious conditions.

"This new laser with yellow light is currently the only one of its caliber in the U.S., and there's only one other being used in the world right now," said Quan Dong Nguyen, M.D., the McGaw Memorial Endowed Chair in Ophthalmology and director of the Eye Institute.

On July 22, the first patient received treatment from the laser for proliferative diabetic retinopathy, the most severe stage of eye disease caused by diabetes.

"This laser is the most cutting-edge laser device available today," said Diana Do, M.D., associate professor of ophthalmology and director of the Carl Camras Center for Innovative Clinical Research at the Truhlsen Eye Institute and the retina specialist who performed the first treatment.

"It allows us to apply a large number of laser spots in a variety of patterns," Dr. Do said. "Overall, it is more effective, efficient and may be safer than traditional lasers."

Traditional lasers are limited in the number of patterns and pulsing they can accommodate, whereas the new laser allows for more nuanced and problem-specific targeting, Dr. Do said.

The laser provides treatment for various rare eye diseases, including retinal vein occlusion, neovascular glaucoma, and retinal tears. In addition, with micropulse application capability, it also can be combined with other therapies to treat diabetic macular edema, the most common cause of moderate vision loss for diabetes patients.

"With diabetes rates on the rise nationally and in Nebraska, more and more patients will be able to benefit from the superior treatment that new technology like this can bring," Dr. Do said.

The full name of the laser is the Supra Scan Multi-spot Laser. It is manufactured by Quantel Medical, which is headquartered in Paris, France.

The Truhlsen Eye Institute, which opened in two months ago at 3902 Leavenworth St., is the newest building on UNMC's campus and offers state-of-the-art eye care in many eye subspecialties as well as routine prescription and optical shop services.

To make an appointment at the Truhlsen Eye Institute, please call 402-559-2020.

Through world-class research and patient care, UNMC generates breakthroughs that make life better for people throughout Nebraska and beyond. Its education programs train more health professionals than any other institution in the state. Learn more at unmc.edu.


Story Source:

Materials provided by University of Nebraska Medical Center (UNMC). Note: Content may be edited for style and length.


Cite This Page:

University of Nebraska Medical Center (UNMC). "New laser provides cutting-edge treatment for diabetes, retinal diseases." ScienceDaily. ScienceDaily, 24 September 2013. <www.sciencedaily.com/releases/2013/09/130924090548.htm>.
University of Nebraska Medical Center (UNMC). (2013, September 24). New laser provides cutting-edge treatment for diabetes, retinal diseases. ScienceDaily. Retrieved April 16, 2024 from www.sciencedaily.com/releases/2013/09/130924090548.htm
University of Nebraska Medical Center (UNMC). "New laser provides cutting-edge treatment for diabetes, retinal diseases." ScienceDaily. www.sciencedaily.com/releases/2013/09/130924090548.htm (accessed April 16, 2024).

Explore More

from ScienceDaily

RELATED STORIES